Phospholipid-sensitive Ca2+-dependent protein kinase and its substrates in human neutrophils.

[1]  R. Schatzman,et al.  Purification to homogeneity, characterization and monoclonal antibodies of phospholipid-sensitive Ca2+-dependent protein kinase from spleen. , 1983, The Biochemical journal.

[2]  R. Turner,et al.  Basic Protein in Brain Myelin Is Phosphorylated by Endogenous Phospholipid‐Sensitive Ca2+‐Dependent Protein Kinase , 1982, Journal of neurochemistry.

[3]  H. Hidaka,et al.  Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives. , 1982, Molecular pharmacology.

[4]  R. Turner,et al.  Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents. , 1982, The Journal of biological chemistry.

[5]  J. Kuo,et al.  Phospholipid-sensitive Ca2+-dependent protein kinase from heart. I. Purification and general properties. , 1982, The Journal of biological chemistry.

[6]  J. Kuo,et al.  Stimulation by phospholipid of calcium-dependent phosphorylation of endogenous proteins from mammalian tissues. , 1981, Biochimica et biophysica acta.

[7]  P. Naccache,et al.  Calmodulin antagonists modulate rabbit neutrophil degranulation, aggregation and stimulated oxygen consumption. , 1981, Biochimica et biophysica acta.

[8]  J. Kuo,et al.  Inhibition by adriamycin of calmodulin-sensitive and phospholipid-sensitive calcium-dependent phosphorylation of endogenous proteins from heart. , 1981, The Biochemical journal.

[9]  J. Kuo,et al.  Stimulation by phosphatidylserine and calmodulin of calcium-dependent phosphorylation of endogenous proteins from cerebral cortex. , 1980, The Journal of biological chemistry.

[10]  T. Stossel,et al.  Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate. , 1980, Blood.

[11]  W. Y. Cheung,et al.  Calmodulin plays a pivotal role in cellular regulation. , 1980, Science.

[12]  M. J. Cormier,et al.  Purification of plant calmodulin by fluphenazine-Sepharose affinity chromatography. , 1979, Biochemical and biophysical research communications.

[13]  R. Smith,et al.  The guinea pig neutrophil calcium-dependent lysosomal enzyme secretory process. , 1979, Biochemical pharmacology.

[14]  Y Nishizuka,et al.  Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. , 1979, The Journal of biological chemistry.

[15]  L. Simchowitz,et al.  Generation of superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium. , 1979, The Journal of laboratory and clinical medicine.

[16]  G. Weissmann,et al.  Microfilaments and microtubules in calcium ionophore-induced secretion of lysosomal enzymes from human polymorphonuclear leukocytes , 1978, The Journal of cell biology.

[17]  G. Siest,et al.  Protein and enzyme release from human leukocytes: influence of phenothiazine derivatives. , 1977, Chemico-biological interactions.

[18]  B. Björkstén,et al.  Inhibition of human neutrophil chemotaxis in vitro by phenothiazines and related compounds , 1976, Infection and immunity.

[19]  R. Snyderman,et al.  Calcium influx requirement for human neutrophil chemotaxis: inhibition by lanthanum chloride. , 1976, Science.

[20]  J. Kuo,et al.  Isolation of stimulatory modulator of guanosine 3':5'-monophosphate-dependent protein kinase from mammalian heart devoid of inhibitory modulator of adenosine 3':5'-monophosphate-dependent protein kinase. , 1976, The Journal of biological chemistry.

[21]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[22]  J. Gallin,et al.  THE REGULATORY ROLE OF DIVALENT CATIONS IN HUMAN GRANULOCYTE CHEMOTAXIS , 1974, The Journal of cell biology.

[23]  T. Stossel.  QUANTITATIVE STUDIES OF PHAGOCYTOSIS , 1973, The Journal of cell biology.

[24]  T. Tanaka,et al.  Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase. , 1980, Molecular pharmacology.

[25]  R. Post,et al.  [118] 32P-labeling of a (Na+ + K+)-ATPase intermediate , 1967 .